Depiction of Prostate Cancer Treatment Alternatives in Greece
A retrospective, registry analysis of the socio-economic and demographic characteristics of patients suffering from locally advanced or metastatic prostate cancer, as well as the depiction of the therapeutic algorithms followed in the Greek clinical practice.
- Target Group: Patients with locally advanced or metastatic prostate cancer.
- The first 10 consecutive patients records that meet the entry criteria.
Locally Advanced or Metastatic Prostate Cancer.
|Study Design:||Observational Model: Case-Only
Time Perspective: Retrospective
|Official Title:||Depiction of Prostate Cancer Treatment Alternatives in Greece|
- Percentage of patients treated by each treatment alternative. [ Time Frame: Between 2002 - 2008 ]
- To depict sociodemographic characteristics and comorbidities. [ Time Frame: Between 2002 - 2008 ]
|Study Start Date:||January 2008|
|Study Completion Date:||March 2009|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00733213
|Study Director:||Panagiotis Pontikis, MD||AstraZeneca Greece|